PMID: 8454491Mar 15, 1993Paper

Measured dose to ovaries and testes from Hodgkin's fields and determination of genetically significant dose

International Journal of Radiation Oncology, Biology, Physics
A Niroomand-Rad, R Cumberlin

Abstract

To determine the genetically significant dose from therapeutic radiation exposure with Hodgkin's fields by estimating the doses to ovaries and testes. Phantom measurements were performed to verify estimated doses to ovaries and testes from Hodgkin's fields. Thermoluminescent LiF dosimeters (TLD-100) of 1 x 3 x 3 mm3 dimensions were embedded in phantoms and exposed to standard mantle and paraaortic fields using Co-60, 4 MV, 6 MV, and 10 MV photon beams. Our results show that measured doses to ovaries and testes are about two to five times higher than the corresponding graphically estimated doses for Co-60 and 4 MVX photon beams as depicted in ICRP publication 44. In addition, the measured doses to ovaries and testes are about 30% to 65% lower for 10 MV photon beams than for their corresponding Co-60 photon beams. The genetically significant dose from Hodgkin's treatment (less than 0.01 mSv) adds about 4% to the genetically significant dose contribution to medical procedures and adds less than 1% to the genetically significant dose from all sources. Therefore, the consequence to society is considered to be very small. The consequences for the individual patient are, likewise, small.

References

May 1, 1976·The International Journal of Applied Radiation and Isotopes·P BassiO Rimondi
Nov 1, 1983·Medical Physics·B A Fraass, J van de Geijn
Oct 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H Kubo, W U Shipley

❮ Previous
Next ❯

Citations

Jul 15, 1996·International Journal of Radiation Oncology, Biology, Physics·P H Van der Giessen
Jan 1, 1995·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·S MarcieJ L Lagrange
Mar 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P H Van der Giessen
Mar 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P H Van der Giessen, H W Bierhuizen
Jan 14, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A ShamsaldinJ Chavaudra
Jul 7, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S BieriR Miralbell
Mar 15, 1997·International Journal of Radiation Oncology, Biology, Physics·I J DasB Fowble
Oct 16, 2004·The British Journal of Radiology·M MazonakisN Gourtsoyiannis
Sep 1, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M David, A D Ebert
Mar 6, 2004·Medical Physics·Robin L SternZelanna Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
B A FraassE Glatstein
International Journal of Radiation Oncology, Biology, Physics
S C SharmaC K Lee
International Journal of Radiation Oncology, Biology, Physics
S Sherazi, K R Kase
International Journal of Radiation Oncology, Biology, Physics
K R KaseM A Marks
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
S MarcieJ L Lagrange
© 2021 Meta ULC. All rights reserved